Massachusetts Cannabis Industry Launches Campaign Against Repeal Measure

Industry Coalition Forms Defense PAC

A coalition of Massachusetts cannabis licensees filed paperwork June 24 to establish a political action committee opposing the repeal ballot question. The committee, registered with the Massachusetts Office of Campaign and Political Finance as "Protect Massachusetts Cannabis," lists representatives from multi-state operators Curaleaf and Trulieve alongside locally licensed cultivators and retailers. The PAC reported an initial funding commitment of $2.3 million, according to OCPF disclosure forms.

Seven of the state's top ten revenue-generating retailers joined as founding members. The coalition includes the Cannabis Control Commission's largest license holders by revenue.

Ballot Question Seeks Full Repeal

The November ballot measure would repeal Chapter 334 of the Acts of 2016, the statute authorizing adult-use cannabis sales in Massachusetts. Proponents submitted 112,000 certified signatures to the Secretary of the Commonwealth in May, exceeding the 74,574-signature threshold required to place a statutory repeal question on the ballot. If approved by voters, the measure would immediately prohibit all adult-use cultivation, manufacturing, testing, and retail operations.

Medical cannabis licenses issued under Chapter 369 of the Acts of 2012 would remain valid. Personal possession and home cultivation rights established under earlier decriminalization statutes wouldn't be affected by the repeal question.

Economic Stakes for Licensed Operators

Massachusetts adult-use cannabis sales totaled $1.87 billion in fiscal year 2025, generating $287 million in excise and sales tax revenue. The Cannabis Control Commission currently licenses 412 active retail locations, 189 cultivation facilities, and 87 product manufacturers statewide. Industry employment reached 14,200 full-time-equivalent positions as of March 2026, according to CCC workforce data.

A full repeal would trigger immediate license revocation. State law provides no grace period or phase-out mechanism for existing operations. Licensed businesses would face immediate closure and asset liquidation.

Repeal Campaign Cites Public Health Concerns

The repeal campaign, organized as "Safer Massachusetts," argues that legalization has increased youth access and impaired driving incidents. Campaign literature cites Massachusetts Department of Public Health data showing a 14% increase in cannabis-related emergency department visits among patients aged 12-20 between 2020 and 2024. State Police collision reports indicate THC-positive toxicology results in 8.3% of fatal motor vehicle crashes in 2025, up from 5.1% in 2019.

Public health researchers have noted that correlation doesn't establish causation in toxicology data. THC metabolites remain detectable for weeks after consumption and don't confirm impairment at the time of a crash.

Campaign Strategy and Timeline

The industry PAC plans a $4.5 million television and digital advertising campaign launching in August. Campaign materials will emphasize tax revenue loss, job elimination, and the persistence of illicit markets if legal sales end. Boston-based political consulting firm Dewey Square Group will manage voter outreach and polling.

Polling commissioned by the Massachusetts Cannabis Industry Association in April showed 52% of likely voters opposed repeal. Thirty-eight percent supported it. Ten percent remained undecided. When respondents heard public health arguments, the margin narrowed to 48-44.

Legislative Response and Regulatory Uncertainty

The Massachusetts Legislature hasn't introduced companion legislation to address ballot-measure concerns through regulatory reform. House Speaker Ronald Mariano told reporters June 23 that the chamber wouldn't take up cannabis policy amendments before the November election. Senate President Karen Spilka declined to comment on potential legislative action.

New license application reviews are on hold pending the election outcome. CCC Executive Director Shawn Collins said in a June 20 memo that the agency wouldn't process applications for licenses that might be invalidated within months.

Implications for Multi-State Operators

Massachusetts represents the fourth-largest adult-use cannabis market by revenue among U.S. states. Multi-state operators including Curaleaf, Trulieve, Verano, and Cresco Labs operate a combined 89 retail locations in the state. A repeal would force write-downs of Massachusetts-based assets and eliminate a significant revenue stream for publicly traded cannabis companies.

Curaleaf reported $198 million in Massachusetts revenue for fiscal year 2025, representing 11% of the company's total sales. Trulieve's Massachusetts operations generated $142 million, or 8% of company revenue. Both companies have indicated they'd pursue legal challenges if voters approve repeal, though the state constitution provides limited grounds for overturning voter-approved statutory changes.

For comprehensive coverage of this ballot measure and its implications, see the CannIntel topic hub on the Massachusetts cannabis repeal effort.